Following the Supreme Court's decision to overturn Roe v. Wade, access to mifepristone has become increasingly limited in many states. A recent study shows that ulipristal acetate, an FDA-approved emergency contraceptive, could be a viable alternative for those seeking an abortion. In trials conducted in Mexico City, women who took a double dose of ulipristal acetate followed by misoprostol experienced a 97% success rate in terminating early pregnancies, highlighting a potential new avenue for reproductive rights amid mounting restrictions in the U.S.
A recent study indicates that ulipristal acetate, when used as an alternative to mifepristone, may effectively terminate early pregnancies, offering a potential solution for accessing abortion.
In a trial involving over 100 women, researchers found that a regimen of ulipristal acetate followed by misoprostol terminated 97% of pregnancies, suggesting this could be a viable alternative.
Collection
[
|
...
]